MTAP

Last updated
MTAP
Protein MTAP PDB 1cb0.png
Available structures
PDB Ortholog search: PDBe RCSB
Identifiers
Aliases MTAP , BDMF, DMSFH, DMSMFH, HEL-249, LGMBF, MSAP, c86fus, methylthioadenosine phosphorylase
External IDs OMIM: 156540 MGI: 1914152 HomoloGene: 1838 GeneCards: MTAP
Orthologs
SpeciesHumanMouse
Entrez

4507

66902

Ensembl

ENSG00000099810

ENSMUSG00000062937

UniProt

Q13126

Q9CQ65

RefSeq (mRNA)

NM_002451

NM_024433

RefSeq (protein)

NP_002442

NP_077753

Location (UCSC) Chr 9: 21.8 – 21.94 Mb Chr 4: 89.06 – 89.1 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

S-methyl-5'-thioadenosine phosphorylase (MTAP) is an enzyme in humans responsible for polyamine metabolism. It is encoded by the methylthioadenosine phosphorylase (MTAP) gene on chromosome 9. [5] Multiple alternatively spliced transcript variants have been described for this gene, but their full-length natures remain unknown. [6]

This gene encodes an enzyme that plays a major role in polyamine metabolism and is important for the salvage of both adenine and methionine. It is responsible for the first step in this pathway, where it catalyzes the reversible phosphorylation of MTA to adenine and 5-methylthioribose-1-phosphate. This takes place after MTA is generated from S-adenosylmethionine. [5]

A summary of the reaction that MTAP catalyzes. MTAP reaction Summary.png
A summary of the reaction that MTAP catalyzes.

MTAP was identified for the first time and characterized likely as a phosphorylase in 1969 by Pegg and Williams-Ashman. [7] The first purification that allowed characterization was by a group in 1986. [8] This purification allowed researchers to investigate why there is the lower expression of MTAP in some types of cancer.

Increased levels of MTA in tumor cells along with lower expression of MTAP. [9] The enzyme is deficient in many cancers because this gene and the tumor-suppressive p16 gene are co-deleted. [9] [10] [11] [12] [13]

Gene

The MTAP gene location is 9p21.3 which is chromosome 9, p arm, band 2, sub-band1, and sub-sub-band 3. [14] [15] The MTAP gene has seven isomers which are created when mRNA’s of the same locus have different transcription start sites. [16] Due to the nature of the MTAP gene and the surrounding genes of chromosome 9, deletion of the genes around p21, and gene p21 are common. [17] Particularly the deletion of the gene p16 in conjunction with the whole or partial deletion of MTAP has been indicated in some cancer types. [17] Genes p15 and p16 of chromosome nine are closely linked to the MTAP gene, because of this, MTAP is commonly cross-deleted. [10] [11] [17] This deletion is found in many cancerous tissues. [10] [11]

Structure

MTAP Subunit Secondary Structure with active site indicated in purple. MTAP Secondary Subunit Structure.jpg
MTAP Subunit Secondary Structure with active site indicated in purple.
MTAP quaternary structure with different subunits indicated by different colors (red, blue, and green). Generated using PyMol. MTAP Quaternary Structure.png
MTAP quaternary structure with different subunits indicated by different colors (red, blue, and green). Generated using PyMol.

MTAP is a trimer enzyme that shares a similar structure and functions with mammalian purine nucleoside phosphorylases (PNPs) which are also trimeric enzymes. [18] MTAP’s subunits are identical in structure and composed of 283 amino acid residues that form to the size of about 32 kDa each. [8] [18] The main structure of an MTAP subunit consists of eleven beta-sheets with six alpha-helices intermixed. [18] The active site of the enzyme is made up of beta-sheets five and 11, as well as alpha-helix 5, and four separate residue loop structures. [18] Within MTAP, helix six is a 12-residue C-terminal helix that arranges for the leucine residue 279 of one subunit to be a part of the active site of another subunit. [18] The active site of each subunit includes two residues (His137 and Leu279) from a neighboring subunit, relying on the interactions between the subunits for proper enzymatic activity. [18] MTAP contains an active site with three regions that correspond to a base, methylthioribose, and sulfate/phosphate binding site. [18]

Function

Methionine Salvage Pathway and Polyamine Pathways of the MTAP enzyme. Methionine Salvage Pathway and Polyamine Pathways.png
Methionine Salvage Pathway and Polyamine Pathways of the MTAP enzyme.

S-methyl-5'-thioadenosine phosphorylase, MTAP, primarily functions to salvage adenine and methionine from molecule methylthioadenosine (MTA), a byproduct of the polyamine pathway. MTAP is a phosphorylase, which is an enzyme that catalyzes the addition of an inorganic phosphate to another molecule. MTAP is responsible for the cleaving of its substrate, MTA, into adenine and 5-methylthioribose-1-phosphate by the addition of the inorganic phosphate to the 1-prime carbon of the ribose sugar unit MTA. [18] The 5-methylthioribose-1-phosphate is then cycled into the salvage pathway and metabolized into methionine. [20] [21] The MTAP enzyme is responsible for nearly all the adenine synthesis in the human body. [18] Adenine is one of the purine bases of nucleic acids, which build both DNA and RNA. Through the recovery of adenine, MTAP plays a highly critical indirect role in the synthesis of DNA and RNA.

Cancer

In recent years a connection between tumor growth, cancer developments, and the enzyme MTAP. Research studies show that tumor cells have lower expression of MTAP enzymes and a higher concentration of the MTA molecule. [9] This trend can be easily understood through the polyamine pathway where MTAP functions to cleave its substrate MTA. [9] [22] In healthy cells, the molecule MTA is believed to have tumor suppressing properties and regulate cell proliferation. [22] However, when MTA levels were recorded above optimal working conditions, these MTA molecules appeared to have an inverse relation, promoting tumor growth and significantly increasing the proliferation of tumor cells. [9] These increased levels of MTA in tumor cells is in direct correlation to a down regulation or complete deletion of the gene encoding the MTAP enzyme. [9]

Related Research Articles

<span class="mw-page-title-main">Kinase</span> Enzyme catalyzing transfer of phosphate groups onto specific substrates

In biochemistry, a kinase is an enzyme that catalyzes the transfer of phosphate groups from high-energy, phosphate-donating molecules to specific substrates. This process is known as phosphorylation, where the high-energy ATP molecule donates a phosphate group to the substrate molecule. This transesterification produces a phosphorylated substrate and ADP. Conversely, it is referred to as dephosphorylation when the phosphorylated substrate donates a phosphate group and ADP gains a phosphate group. These two processes, phosphorylation and dephosphorylation, occur four times during glycolysis.

<span class="mw-page-title-main">Ornithine decarboxylase</span>

The enzyme ornithine decarboxylase catalyzes the decarboxylation of ornithine to form putrescine. This reaction is the committed step in polyamine synthesis. In humans, this protein has 461 amino acids and forms a homodimer.

A salvage pathway is a pathway in which a biological product is produced from intermediates in the degradative pathway of its own or a similar substance. The term often refers to nucleotide salvage in particular, in which nucleotides are synthesized from intermediates in their degradative pathway.

<span class="mw-page-title-main">Fusion gene</span>

A fusion gene is a hybrid gene formed from two previously independent genes. It can occur as a result of translocation, interstitial deletion, or chromosomal inversion. Fusion genes have been found to be prevalent in all main types of human neoplasia. The identification of these fusion genes play a prominent role in being a diagnostic and prognostic marker.

p16 Mammalian protein found in Homo sapiens

p16, is a protein that slows cell division by slowing the progression of the cell cycle from the G1 phase to the S phase, thereby acting as a tumor suppressor. It is encoded by the CDKN2A gene. A deletion in this gene can result in insufficient or non-functional p16, accelerating the cell cycle and resulting in many types of cancer.

<span class="mw-page-title-main">Oncogenomics</span> Sub-field of genomics

Oncogenomics is a sub-field of genomics that characterizes cancer-associated genes. It focuses on genomic, epigenomic and transcript alterations in cancer.

<span class="mw-page-title-main">Cyclin-dependent kinase 6</span> Protein-coding gene in the species Homo sapiens

Cell division protein kinase 6 (CDK6) is an enzyme encoded by the CDK6 gene. It is regulated by cyclins, more specifically by Cyclin D proteins and Cyclin-dependent kinase inhibitor proteins. The protein encoded by this gene is a member of the cyclin-dependent kinase, (CDK) family, which includes CDK4. CDK family members are highly similar to the gene products of Saccharomyces cerevisiae cdc28, and Schizosaccharomyces pombe cdc2, and are known to be important regulators of cell cycle progression in the point of regulation named R or restriction point.

<span class="mw-page-title-main">HMGA2</span> Protein-coding gene in the species Homo sapiens

High-mobility group AT-hook 2, also known as HMGA2, is a protein that, in humans, is encoded by the HMGA2 gene.

<span class="mw-page-title-main">PRKACA</span> Protein-coding gene in the species Homo sapiens

The catalytic subunit α of protein kinase A is a key regulatory enzyme that in humans is encoded by the PRKACA gene. This enzyme is responsible for phosphorylating other proteins and substrates, changing their activity. Protein kinase A catalytic subunit is a member of the AGC kinase family, and contributes to the control of cellular processes that include glucose metabolism, cell division, and contextual memory. PKA Cα is part of a larger protein complex that is responsible for controlling when and where proteins are phosphorylated. Defective regulation of PKA holoenzyme activity has been linked to the progression of cardiovascular disease, certain endocrine disorders and cancers.

<span class="mw-page-title-main">TYMP (gene)</span> Protein-coding gene in the species Homo sapiens

TYMP is a gene that encodes for the enzyme thymidine phosphorylase. The TYMP gene is also known as ECGF1 and MNGIE due to its role in MNGIE syndrome.

<span class="mw-page-title-main">S-methyl-5'-thioadenosine phosphorylase</span>

In enzymology, a S-methyl-5'-thioadenosine phosphorylase is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">Thymidine phosphorylase</span> Enzyme

Thymidine phosphorylase is an enzyme that is encoded by the TYMP gene and catalyzes the reaction:

<span class="mw-page-title-main">CDKN2B</span> Protein-coding gene in the species Homo sapiens

Cyclin-dependent kinase 4 inhibitor B also known as multiple tumor suppressor 2 (MTS-2) or p15INK4b is a protein that is encoded by the CDKN2B gene in humans.

<span class="mw-page-title-main">PHKA2</span> Protein-coding gene in the species Homo sapiens

Phosphorylase b kinase regulatory subunit alpha, liver isoform is an enzyme that in humans is encoded by the PHKA2 gene.

<span class="mw-page-title-main">CDKN2A</span> Protein-coding gene in the species Homo sapiens

CDKN2A, also known as cyclin-dependent kinase inhibitor 2A, is a gene which in humans is located at chromosome 9, band p21.3. It is ubiquitously expressed in many tissues and cell types. The gene codes for two proteins, including the INK4 family member p16 and p14arf. Both act as tumor suppressors by regulating the cell cycle. p16 inhibits cyclin dependent kinases 4 and 6 and thereby activates the retinoblastoma (Rb) family of proteins, which block traversal from G1 to S-phase. p14ARF activates the p53 tumor suppressor. Somatic mutations of CDKN2A are common in the majority of human cancers, with estimates that CDKN2A is the second most commonly inactivated gene in cancer after p53. Germline mutations of CDKN2A are associated with familial melanoma, glioblastoma and pancreatic cancer. The CDKN2A gene also contains one of 27 SNPs associated with increased risk of coronary artery disease.

<span class="mw-page-title-main">PHKG2</span> Protein-coding gene in the species Homo sapiens

Phosphorylase b kinase gamma catalytic chain, testis/liver isoform is an enzyme that in humans is encoded by the PHKG2 gene.

<span class="mw-page-title-main">TUSC3</span> Protein-coding gene in the species Homo sapiens

Tumor suppressor candidate 3 is a protein that in humans is encoded by the TUSC3 gene.

<span class="mw-page-title-main">UPP1</span> Protein-coding gene in the species Homo sapiens

Uridine phosphorylase 1 is an enzyme that in humans is encoded by the UPP1 gene. It belongs to the uridine phosphorylase enzyme family.

<span class="mw-page-title-main">CACNA2D2</span> Protein-coding gene in the species Homo sapiens

Voltage-dependent calcium channel subunit alpha2delta-2 is a protein that in humans is encoded by the CACNA2D2 gene.

<span class="mw-page-title-main">ADP/ATP translocase 2</span> Protein-coding gene in humans

ADP/ATP translocase 2 is a protein that in humans is encoded by the SLC25A5 gene on the X chromosome.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000099810 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000062937 - Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 3 "MTAP - S-methyl-5'-thioadenosine phosphorylase - Homo sapiens (Human) - MTAP gene & protein". www.uniprot.org. Retrieved 2021-12-03.
  6. ↑ "MTAP methylthioadenosine phosphorylase [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2021-12-03.
  7. ↑ Pegg AE, Williams-Ashman HG (November 1969). "Phosphate-stimulated breakdown of 5'-methylthioadenosine by rat ventral prostate". The Biochemical Journal. 115 (2): 241–247. doi:10.1042/bj1150241. PMC   1185095 . PMID   5378381.
  8. 1 2 Della Ragione F, Cartenì-Farina M, Gragnaniello V, Schettino MI, Zappia V (September 1986). "Purification and characterization of 5'-deoxy-5'-methylthioadenosine phosphorylase from human placenta". The Journal of Biological Chemistry. 261 (26): 12324–12329. doi: 10.1016/S0021-9258(18)67242-4 . PMID   3091600.
  9. 1 2 3 4 5 6 Kirovski G, Stevens AP, Czech B, Dettmer K, Weiss TS, Wild P, et al. (March 2011). "Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA)". The American Journal of Pathology. 178 (3): 1145–1152. doi:10.1016/j.ajpath.2010.11.059. PMC   3069916 . PMID   21356366.
  10. 1 2 3 Barekatain Y, Ackroyd JJ, Yan VC, Khadka S, Wang L, Chen KC, et al. (July 2021). "Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine". Nature Communications. 12 (1): 4228. Bibcode:2021NatCo..12.4228B. doi:10.1038/s41467-021-24240-3. PMC   8270912 . PMID   34244484.
  11. 1 2 3 Menezes WP, Silva VA, Gomes IN, Rosa MN, Spina ML, Carloni AC, et al. (February 2020). "Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness". Cells. 9 (2): 492. doi: 10.3390/cells9020492 . PMC   7072758 . PMID   32093414.
  12. ↑ Xu J, Chang WH, Fong LW, Weiss RH, Yu SL, Chen CH (2019-01-25). "Targeting the insulin-like growth factor-1 receptor in MTAP-deficient renal cell carcinoma". Signal Transduction and Targeted Therapy. 4: 2. doi:10.1038/s41392-019-0035-z. PMC   6345872 . PMID   30701095.
  13. ↑ Hansen LJ, Sun R, Yang R, Singh SX, Chen LH, Pirozzi CJ, et al. (July 2019). "MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation". Cancer Research. 79 (13): 3383–3394. doi:10.1158/0008-5472.CAN-18-1010. PMC   6810595 . PMID   31040154.
  14. ↑ "MTAP Gene". www.genecards.org. Retrieved 2021-10-06.
  15. ↑ "MLA CE Course Manual: Molecular Biology Information Resources (Genetics Review: Chromosome Band Numbers)". www.ncbi.nlm.nih.gov. Retrieved 2021-10-06.
  16. ↑ "UniProtKB - Q13126 (MTAP_Human)". UniProt. Retrieved October 5, 2021.
  17. 1 2 3 Nobori T, Takabayashi K, Tran P, Orvis L, Batova A, Yu AL, Carson DA (June 1996). "Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers". Proceedings of the National Academy of Sciences of the United States of America. 93 (12): 6203–6208. Bibcode:1996PNAS...93.6203N. doi: 10.1073/pnas.93.12.6203 . PMC   39214 . PMID   8650244.
  18. 1 2 3 4 5 6 7 8 9 10 Appleby TC, Erion MD, Ealick SE (June 1999). "The structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase at 1.7 A resolution provides insights into substrate binding and catalysis". Structure. 7 (6): 629–641. doi: 10.1016/S0969-2126(99)80084-7 . PMID   10404592.
  19. ↑ Bank, RCSB Protein Data. "RCSB PDB - 3OZE: Crystal Structure of human 5'-deoxy-5'-methyladenosine phosphorylase". www.rcsb.org. Retrieved 2021-12-02.
  20. 1 2 Subhi AL, Diegelman P, Porter CW, Tang B, Lu ZJ, Markham GD, Kruger WD (December 2003). "Methylthioadenosine phosphorylase regulates ornithine decarboxylase by production of downstream metabolites". The Journal of Biological Chemistry. 278 (50): 49868–49873. doi: 10.1074/jbc.M308451200 . PMID   14506228.
  21. ↑ Bertino JR, Waud WR, Parker WB, Lubin M (April 2011). "Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: current strategies". Cancer Biology & Therapy. 11 (7): 627–632. doi:10.4161/cbt.11.7.14948. PMC   3084968 . PMID   21301207.
  22. 1 2 Li Y, Wang Y, Wu P (January 2019). "5'-Methylthioadenosine and Cancer: old molecules, new understanding". Journal of Cancer. 10 (4): 927–936. doi:10.7150/jca.27160. PMC   6400808 . PMID   30854099.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.